SimLi Medical: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SimLi Medical
Largest movements
- Cash +€53,320
up €53,320 (+159%), from €33,444 to €86,764
mainly Net result for the year (+€84,986) and Tax, wage and social debts (+€19,721)
- Deferred charges and accrued income +€29,121
up €29,121 (+1,767%), from €1,648 to €30,769
- Reserves +€84,986
up €84,986 (+873%), from €9,729 to €94,715
- Other debts -€22,065
down €22,065 (-58.4%), from €37,764 to €15,699
- Tax, wage and social debts +€19,721
up €19,721 (+495%), from €3,983 to €23,703
- Gross operating margin +€91,114
up €91,114 (+524%), from €17,381 to €108,495
- Taxes +€20,221
up €20,221 (+581%), from €3,483 to €23,703
- Depreciation -€2,614
no longer reported in 2025 (was €2,614)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €58,709 | €141,738 | +€83,029 | +141% |
| Current assets | 29/58 | €58,709 | €141,738 | +€83,029 | +141% |
| Amounts receivable after more than one year | 29 | €23,500 | €23,500 | = | 0.0% |
| Other amounts receivable | 291 | €23,500 | €23,500 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €118 | €705 | +€588 | +500% |
| Other amounts receivable | 41 | €118 | €705 | +€588 | +500% |
| Cash at bank and in hand | 54/58 | €33,444 | €86,764 | +€53,320 | +159% |
| Deferred charges and accrued income | 490/1 | €1,648 | €30,769 | +€29,121 | +1,767% |
| Total equity and liabilities | 10/49 | €58,709 | €141,738 | +€83,029 | +141% |
| Equity | 10/15 | €12,729 | €97,715 | +€84,986 | +668% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €9,729 | €94,715 | +€84,986 | +873% |
| Distributable reserves | 133 | €9,729 | €94,715 | +€84,986 | +873% |
| Amounts payable | 17/49 | €45,980 | €44,023 | -€1,957 | -4.3% |
| Amounts payable within one year | 42/48 | €43,677 | €40,680 | -€2,997 | -6.9% |
| Trade debts | 44 | €1,930 | €1,278 | -€652 | -33.8% |
| Suppliers | 440/4 | €1,930 | €1,278 | -€652 | -33.8% |
| Taxes, remuneration and social security | 45 | €3,983 | €23,703 | +€19,721 | +495% |
| Taxes | 450/3 | €3,983 | €23,703 | +€19,721 | +495% |
| Other amounts payable | 47/48 | €37,764 | €15,699 | -€22,065 | -58.4% |
| Accrued charges and deferred income | 492/3 | €2,303 | €3,343 | +€1,040 | +45.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,614 | - | -€2,614 | |
| Other operating charges | 640/8 | - | €209 | +€209 | |
| Gross operating margin | 9900 | €17,381 | €108,495 | +€91,114 | +524% |
| Operating profit (loss) | 9901 | €14,767 | €108,286 | +€93,519 | +633% |
| Financial income | 75/76B | €118 | €743 | +€625 | +532% |
| Recurring financial income | 75 | €118 | €743 | +€625 | +532% |
| Financial charges | 65/66B | €7 | €340 | +€333 | +5,079% |
| Recurring financial charges | 65 | €7 | €340 | +€333 | +5,079% |
| Profit (loss) for the period before taxes | 9903 | €14,878 | €108,689 | +€93,811 | +631% |
| Income taxes | 67/77 | €3,483 | €23,703 | +€20,221 | +581% |
| Profit (loss) for the period | 9904 | €11,395 | €84,986 | +€73,590 | +646% |
| Profit (loss) for the period to be appropriated | 9905 | €11,395 | €84,986 | +€73,590 | +646% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.